RECORD // Company

CRISPR Therapeutics AG

Formerly: CRISPR Therapeutics AG

Built 2026-11-22T00:05:06Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Matched by name only, not merged (11)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • CRISPR THERAPEUTICS INC · Ca business · name equals 'Crispr Therapeutics' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • Crispr Therapeutics, Inc. · Ca business · name equals 'Crispr Therapeutics' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • CRISPR Therapeutics · Ctgov · name equals 'Crispr Therapeutics' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • CRISPR Therapeutics AG · Ctgov · same registered legal name as 'CRISPR Therapeutics AG' Possible match based on name, not a shared identifier. Compare the records. Compare
  • CRISPR THERAPEUTICS · Epa echo · name equals 'Crispr Therapeutics' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • CRISPR THERAPEUTICS · Epa echo · name equals 'Crispr Therapeutics' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • CRISPR THERAPEUTICS · Epa echo · name equals 'Crispr Therapeutics' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • CRISPR THERAPEUTICS · Epa echo · name equals 'Crispr Therapeutics' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • CRISPR THERAPEUTICS AG (lobbying via MMR, LLC) · LDA lobbying · same registered legal name as 'CRISPR Therapeutics AG' Possible match based on name, not a shared identifier. Compare the records. Compare
  • CRISPR THERAPEUTICS INC · Lic sw · name equals 'Crispr Therapeutics' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • CRISPR THERAPEUTICS INC · Seattle business licence certificates · name equals 'Crispr Therapeutics' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare

5 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-02 · accession 0001193125-26-443665

ItemValuePeriodFormFiledAccessionReport
Revenue$12,669,0003 months ended 2026-09-3010-Q2026-11-020001193125-26-4436652026-11-22 00:05 UTCReport an error
Net income (loss)$-111,437,0003 months ended 2026-09-3010-Q2026-11-020001193125-26-4436652026-11-22 00:05 UTCReport an error
Interest expense$3,333,0003 months ended 2026-09-3010-Q2026-11-020001193125-26-4436652026-11-22 00:05 UTCReport an error
Cash and cash equivalents$192,027,000at 2026-09-3010-Q2026-11-020001193125-26-4436652026-11-22 00:05 UTCReport an error
Contract liabilities, current$2,546,000at 2026-09-3010-Q2026-11-020001193125-26-4436652026-11-22 00:05 UTCReport an error

Negative as reported in the filing.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001674416
Ticker
CRSP
EIN
473173478
CUSIP
H17182108
Record ID
sx:sec:0001674416

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

40 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-19SEC EDGAR company profile2026-11-22 00:05 UTCReport an error
SIC industry2836 Biological Products, (No Diagnostic Substances)2026-11-19SEC EDGAR company profile2026-11-22 00:05 UTCReport an error
State of incorporationV82026-11-19SEC EDGAR company profile2026-11-22 00:05 UTCReport an error
Fiscal year end (MMDD)12312026-11-19SEC EDGAR company profile2026-11-22 00:05 UTCReport an error
Business addressBAARERSTRASSE 14, ZUG2026-11-19SEC EDGAR company profile2026-11-22 00:05 UTCReport an error
ExchangesNasdaq2026-11-19SEC EDGAR company profile2026-11-22 00:05 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$3,510,0002025-12-3110-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-22 00:05 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-581,599,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-22 00:05 UTCReport an error
Total assets (at 2025-12-31)$2,265,243,0002025-12-3110-K, XBRL Assets2026-11-22 00:05 UTCReport an error
Stockholders' equity (at 2025-12-31)$1,921,813,0002025-12-3110-K, XBRL StockholdersEquity2026-11-22 00:05 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$347,559,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 00:05 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-345,014,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 00:05 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$914,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 00:05 UTCReport an error
Operating lease liabilities (at 2025-12-31)$206,746,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 00:05 UTCReport an error
Form D total offering amount (D/A filed 2020-04-10)$1,000,0002020-04-10D/A2026-11-22 00:05 UTCReport an error
Form D total amount sold (D/A filed 2020-04-10)$1,000,0002020-04-10D/A2026-11-22 00:05 UTCReport an error
Form D industry groupOther Health Care2020-04-10D/A2026-11-22 00:05 UTCReport an error
Form D revenue rangeDecline to Disclose2020-04-10D/A2026-11-22 00:05 UTCReport an error
Form D date of first sale2020-03-112020-04-10D/A2026-11-22 00:05 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-02)On November 2, 2026, CRISPR Therapeutics AG announced its financial results for the quarter ended September 30, 2026 and other business highlights. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by…2026-11-02SEC EDGAR 8-K 0001193125-26-443644 (text as filed, excerpt)2026-11-22 00:05 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-08-03)On August 3, 2026, CRISPR Therapeutics AG announced its financial results for the quarter ended June 30, 2026 and other business highlights. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific…2026-08-03SEC EDGAR 8-K 0001193125-26-330644 (text as filed, excerpt)2026-11-22 00:05 UTCReport an error
Employer name (as filed)CRISPR Therapeutics, Inc.2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:05 UTCReport an error
Certified LCAs52026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:05 UTCReport an error
Certified LCAs later withdrawn02026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:05 UTCReport an error
Total worker positions on certified LCAs52026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:05 UTCReport an error
Top job titles (title, LCA count)Scientist I, Tech Ops (1); Scientist I, Translational Biology (1); Manager, Clinical Data Management (1); Senior Research Associate, Analytical Development (1); Research Associate II (1)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:05 UTCReport an error
Wage offered, annualized (n, min, median, max)median $125,000 (range $92,000-$138,000, 5 filings)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:05 UTCReport an error
Worksite statesMA2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:05 UTCReport an error
Plan (pension, plan no. 001)CRISPR THERAPEUTICS 401(K) RETIREMENT PLAN: 566 participants, assets $77,241,3642025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 00:05 UTCReport an error
Plan (welfare, plan no. 501)CRISPR THERAPEUTICS INC. HEALTH AND WELFARE PLAN: 405 participants2025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 00:05 UTCReport an error
Largest institutional holder #1 (13F as filed): ARK Investment Management LLC$515,999,6312026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:05 UTCReport an error
Largest institutional holder #2 (13F as filed): BlackRock, Inc.$455,353,1972026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:05 UTCReport an error
Largest institutional holder #3 (13F as filed): Orbis Allan Gray Ltd$297,197,2412026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:05 UTCReport an error
Largest institutional holder #4 (13F as filed): Capital World Investors$259,039,0942026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:05 UTCReport an error
Largest institutional holder #5 (13F as filed): STATE STREET CORP$235,703,6642026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:05 UTCReport an error
Largest institutional holder #6 (13F as filed): GSK plc$175,652,9972026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:05 UTCReport an error
Largest institutional holder #7 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC$136,919,0432026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:05 UTCReport an error
Largest institutional holder #8 (13F as filed): SR One Capital Management, LP$111,194,1342026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:05 UTCReport an error
Largest institutional holder #9 (13F as filed): TWO SIGMA INVESTMENTS, LP$108,459,3892026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:05 UTCReport an error
Largest institutional holder #10 (13F as filed): FMR LLC$104,089,7352026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:05 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.